Terns Pharmaceuticals, Inc.
TERNDelisted May 5, 2026- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001831363
Terns Pharmaceuticals, Inc. was delisted on May 5, 2026; its insiders filed their last Form 4 on May 5, 2026; 317 institutions reported holding it in 13F filings for Q1 2026, worth $6.56B in total; Soros Fund Management was the only superinvestor holding it.
13F holders, Q2 2021
Institutional positions in Terns Pharmaceuticals, Inc. as of Jun 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 36
- −6 vs. Q1 2021
- Shares held
- 16.6M
- −1.28M (−7.2%) vs. Q1 2021
- Total value
- $203.8M
- −$189.9M (−48.2%) vs. Q1 2021
- New holders
- 6
- 11 more added
- Sold out
- 12
- 11 more reduced
Compare with Q1 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting TERN on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 1 | $75.4K |
| Q1 2026 | 317 | $6.56B |
| Q4 2025 | 248 | $4.95B |
| Q3 2025 | 141 | $665.7M |
| Q2 2025 | 130 | $310.0M |
| Q1 2025 | 138 | $229.4M |
| Q4 2024 | 157 | $477.2M |
| Q3 2024 | 156 | $663.1M |
| Q2 2024 | 126 | $446.7M |
| Q1 2024 | 112 | $414.8M |
| Q4 2023 | 103 | $412.7M |
| Q3 2023 | 93 | $310.4M |
| Q2 2023 | 103 | $505.0M |
| Q1 2023 | 79 | $630.2M |
| Q4 2022 | 65 | $506.2M |
| Q3 2022 | 45 | $178.1M |
| Q2 2022 | 42 | $36.5M |
| Q1 2022 | 44 | $50.0M |
| Q4 2021 | 37 | $116.7M |
| Q3 2021 | 34 | $174.3M |
| Q2 2021 | 36 | $203.8M |
| Q1 2021 | 42 | $393.7M |
Institutions, Q2 2021
Shares, value and share of portfolio for each institution holding Terns Pharmaceuticals, Inc.; share changes are against Q1 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Signaturefd, LLC | 60 | $1.00K | 0.00% | +60 | New |
| Citigroup Inc | 415 | $5.00K | 0.00% | −163−28.2% | Reduced |
| Royal Bank of Canada | 596 | $7.00K | 0.00% | −198−24.9% | Reduced |
| Ameritas Investment Partners, Inc. | 708 | $9.00K | 0.00% | 00.0% | Unchanged |
| Legal & General Group Plc | 879 | $11.0K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 1,180 | $14.0K | 0.00% | +566+92.2% | Added |
| American International Group, Inc. | 4,883 | $60.0K | 0.00% | −192−3.8% | Reduced |
| Bank of America Corp | 4,975 | $61.0K | 0.00% | −4,512−47.6% | Reduced |
| Deutsche Bank AG | 5,894 | $72.0K | 0.00% | +408+7.4% | Added |
| New York State Common Retirement Fund | 5,869 | $72.0K | 0.00% | +1,969+50.5% | Added |
| Balyasny Asset Management LLC | 10,308 | $126.0K | 0.00% | +10,308 | New |
| JPMorgan Chase & Co | 11,419 | $140.0K | 0.00% | −12,117−51.5% | Reduced |
| Jane Street Group, LLC | 11,973 | $147.0K | 0.00% | +11,973 | New |
| California State Teachers Retirement System | 12,038 | $148.0K | 0.00% | −1,097−8.4% | Reduced |
| Nuveen Asset Management, LLC | 14,237 | $175.0K | 0.00% | +152+1.1% | Added |
| Millennium Management LLC | 14,769 | $181.0K | 0.00% | +14,769 | New |
| Jacobs Levy Equity Management, Inc | 17,650 | $216.0K | 0.00% | +17,650 | New |
| Citadel Advisors LLC | 18,200 | $223.0K | 0.00% | −14,421−44.2% | Reduced |
| Caas Capital Management LP | 20,447 | $251.0K | 0.01% | −329,553−94.2% | Reduced |
| Charles Schwab Investment Management Inc | 21,359 | $262.0K | 0.00% | 00.0% | Unchanged |
| Bank of New York Mellon Corp | 23,286 | $286.0K | 0.00% | +4,007+20.8% | Added |
| Morgan Stanley | 26,831 | $329.0K | 0.00% | +26,831 | New |
| Cowen and Company, LLC | 85,000 | $1.04M | 0.06% | +60,000+240.0% | Added |
| Northern Trust Corp | 86,783 | $1.06M | 0.00% | −5,004−5.5% | Reduced |
| State Street Corp | 128,703 | $1.58M | 0.00% | +30,056+30.5% | Added |
| Geode Capital Management, LLC | 143,069 | $1.75M | 0.00% | +12,806+9.8% | Added |
| Samsara BioCapital, LLC | 289,068 | $3.54M | 0.47% | −208,487−41.9% | Reduced |
| Vanguard Group Inc | 415,730 | $5.10M | 0.00% | −160,063−27.8% | Reduced |
| BlackRock Inc. | 437,604 | $5.37M | 0.00% | +30,255+7.4% | Added |
| Antara Capital LP | 775,934 | $9.51M | 1.72% | +24,121+3.2% | Added |
| Matthews International Capital Management LLC | 1,071,421 | $13.1M | 0.55% | 00.0% | Unchanged |
| Suvretta Capital Management, LLC | 1,125,136 | $13.8M | 0.21% | 00.0% | Unchanged |
| Deerfield Management Company, L.P. (Series C) | 2,345,959 | $28.8M | 0.51% | 00.0% | Unchanged |
| Vivo Capital, LLC | 2,675,133 | $32.8M | 1.42% | 00.0% | Unchanged |
| FMR LLC | 3,022,557 | $37.1M | 0.00% | +134,819+4.7% | Added |
| OrbiMed Advisors LLC | 3,791,204 | $46.5M | 0.47% | 00.0% | Unchanged |
| Avidity Partners Management LP | 0 | $0 | 0.00% | −400,000−100.0% | Sold out |
| PFM Health Sciences, LP | 0 | $0 | 0.00% | −329,274−100.0% | Sold out |
| Sphera Funds Management Ltd. | 0 | $0 | 0.00% | −70,000−100.0% | Sold out |
| Marshall Wace North America L.P. | 0 | $0 | 0.00% | −41,792−100.0% | Sold out |
| Norges Bank | 0 | $0 | 0.00% | −23,068−100.0% | Sold out |
| Zimmer Partners, LP | 0 | $0 | 0.00% | −22,500−100.0% | Sold out |
| Pinz Capital Management, LP | 0 | $0 | 0.00% | −19,948−100.0% | Sold out |
| Laurion Capital Management LP | 0 | $0 | 0.00% | −15,000−100.0% | Sold out |
| Wells Fargo & Company | 0 | $0 | 0.00% | −2,714−100.0% | Sold out |
| UBS Group AG | 0 | $0 | 0.00% | −2,546−100.0% | Sold out |
| STRS Ohio | 0 | $0 | 0.00% | −2,100−100.0% | Sold out |
| Bank of Montreal | 0 | $0 | 0.00% | −292−100.0% | Sold out |